Part,  Chapter, Paragraph

 1    I,     2.  4    |        volume movements only, i.e. price movements will not inflate
 2    I,     2.  8    |          policy makers. The market price of energy is also very important
 3   II,     5.  3.  7|      without further delays due to price and reimbursement negotiations.~·
 4   II,     5.  3.  7|            medical need (at a high price), but later its efficacy
 5   II,     5.  5.  2|          charge of 50 cents to the price of every pack of medicine
 6   II,     5.  5.  3|     economic indexes adjusting for price level differences in different
 7   II,     5.  6.  6|        63S-7S~Lin CT, Albertson G, Price D, Swaney R, Anderson S,
 8   II,     5.  9.  7|  Neuherberg, Germany~ ~Holgate ST, Price D, Valovirta E (2006): Asthma
 9   II,     5. 12.  5|        fiscal policies to rise the price of alcohol should be adopted,
10   II,     5. 15.  3|           independent study on the price of orphan drugs (OD). The
11   II,     5. 15.  3|           by Alcimed, looks at the price of orphan drugs authorised
12  III,    10.  2.  1|       demand for tobacco products (price, taxation);~· measures to
13  III,    10.  2.  1|   supported by the FCTC include:~· price and tax measures;~· protection
14  III,    10.  2.  1|           of tobacco (e.g. through price and taxation policies) and
15  III,    10.  2.  1|           Maintaining the relative price of alcohol~ ~When other
16  III,    10.  2.  1|      respond to and compensate for price changes is complex, because
17  III,    10.  2.  1|          of an increase in alcohol price is stronger in the longer
18  III,    10.  2.  1|          particularly sensitive to price. Policies that increase
19  III,    10.  2.  1|     drinkers are also sensitive to price, with higher alcohol taxes
20  III,    10.  2.  1|           constrained by increased price competition and the switch
21  III,    10.  2.  1|          plus an alarming economic price to pay for physical inactivity.
22  III,    10.  5.  3|            people ill, with a high price to be paid by individuals,
23   IV,    11.  1.  3|        feasibility and reduced the price of collecting and processing
24   IV,    11.  1.  5|         including safety) not just price~Providers respond to a reduction
25   IV,    11.  1.  6|           be used to influence the price and quantity of healthcare.
26   IV,    11.  3.  2|      pharmaceutical expenditure is price regulation. Common methods
27   IV,    11.  3.  2|       methods include direct fixed price control, profit control,
28   IV,    11.  3.  2|      profit control, international price comparisons and reference
29   IV,    11.  3.  2| comparisons and reference pricing. Price fixing is based on what
30   IV,    11.  3.  2|    determined to be a ‘reasonableprice for the product based on
31   IV,    11.  3.  2|   effectiveness. Setting a maximum price can be done through negotiated
32   IV,    11.  3.  2|            prices, price-caps, and price comparisons with other countries;
33   IV,    11.  3.  2|          government. International price comparisons to determine
34   IV,    11.  3.  2|        pricing, a form of indirect price control, refers to setting
35   IV,    11.  3.  2|         fund - pays. The reference price can be defined in different
36   IV,    11.  3.  2|              the average or median price of drugs with similar pharmacotherapeutic
37   IV,    11.  3.  2|          proportion lower than the price of the original branded
38   IV,    11.  3.  2|          savings through reference price systems have been shown,
39   IV,    11.  3.  2|        depends on a combination of price and volume, direct price
40   IV,    11.  3.  2|           price and volume, direct price regulation schemes may not
41   IV,    11.  3.  2|            increases. Furthermore, price control systems currently
42   IV,    11.  3.  2|          clinical gains. While the price control system in the UK
43   IV,    11.  3.  2|             In Finland a product’s price and reimbursement is explicitly
44   IV,    11.  3.  2|         drugs across EU25 based on price data from 181 pharmaceutical
45   IV,    11.  6.  2|        health services by creating price signals that deter individuals
46   IV,    12.  2    |       demand for tobacco products (price, taxation);~· measures to
47   IV,    12.  2    |     supported by the FCTC include:~price and tax measures;~protection
48   IV,    12.  2    |           Maintaining the relative price of alcohol~ ~When other
49   IV,    12.  2    |      respond to and compensate for price changes is complex, because
50   IV,    12.  2    |          of an increase in alcohol price is stronger in the longer
51   IV,    12.  2    |          particularly sensitive to price. Policies that increase
52   IV,    12.  2    |     drinkers are also sensitive to price, with higher alcohol taxes
53   IV,    12. 10    |            public place~Increasing price of cigarettes~Adoption of
54   IV,    12. 10    |          consumption;~ ~Increasing price of cigarettes~ ~Many prevention
55   IV,    12. 10    |           such measures related to price and accessibility, 4) increasing